The document discusses the role of invariant natural killer T (iNKT) cells in allergic asthma. It finds that iNKT cells produce cytokines like IL-4 and IL-13 that promote Th2 responses and airway hyperreactivity (AHR), and mice lacking iNKT cells do not develop AHR. Studies in humans also find increased iNKT cells in the lungs of asthmatic patients compared to healthy controls. However, the number of iNKT cells may not relate directly to asthma severity. While iNKT cells contribute to asthma pathogenesis, their therapeutic potential is still controversial.